Lumena Pharmaceuticals Receives $45,000,000 Series B Financing Round

  • Feed Type
  • Date
  • Company Name
    Lumena Pharmaceuticals
  • Mailing Address
    12531 High Bluff Drive San Diego, CA 92130
  • Company Description
    Lumena Pharmaceuticals is focused on advancing treatments in metabolic diseases that have high unmet clinical needs.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Lumena will use the funding to advance the clinical development of LUM001, its lead product candidate, for the treatment of rare cholestatic liver disease in pediatric and adult patients, as well as LUM002 for the treatment of nonalcoholic steatohepatitis (NASH).
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Adage Capital Management
  • Venture Investor
    RA Capital
  • Venture Investor
    Pappas Ventures
  • Venture Investor
    RiverVest Venture Partners
  • Venture Investor
    Alta Partners

Trending on Xconomy